KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Cost of Revenue (2021 - 2025)

Aurinia Pharmaceuticals' Cost of Revenue history spans 5 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 58.48% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $32.7 million, up 15.64%, while the annual FY2025 figure was $32.7 million, 15.64% up from the prior year.
  • Cost of Revenue reached $8.8 million in Q4 2025 per AUPH's latest filing, up from $8.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $8.9 million in Q2 2024 to a low of $48000.0 in Q1 2021.
  • Average Cost of Revenue over 5 years is $4.1 million, with a median of $3.9 million recorded in 2022.
  • Peak YoY movement for Cost of Revenue: skyrocketed 1741.33% in 2024, then fell 20.14% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $481000.0 in 2021, then skyrocketed by 183.16% to $1.4 million in 2022, then soared by 296.11% to $5.4 million in 2023, then increased by 2.91% to $5.6 million in 2024, then surged by 58.48% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for AUPH's Cost of Revenue are $8.8 million (Q4 2025), $8.2 million (Q3 2025), and $7.1 million (Q2 2025).